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Volume 56, Number 2 Abstracts 575There were also eight late deaths. One-year survival was 83%  7%. Among
patients with infected endovascular devices, three experienced major late
complications (persistent infection, pseudoaneurysm, and recurrent fistula),
and two of these patients died.
Comment: This is a large series of complex procedures performed for
failure of endovascular abdominal or thoracic aortic devices. Case series of
open removal of endovascular devices seem to be appearing more frequently
as more of these devices are implanted. It is notable that the devices in 71%
of the patients in this series were implanted for off-label indications. Sixty
percent of the patients had been treated for aortic dissection. It also should
be noted that if the device is not infected, the patients can do well with open
removal. However, as whole, patients with infected devices and those with
devices placed for control of fistula have a poor prognosis.
Usefulness of Pre-Operative Copeptin Concentrations to Predict Post-
Operative Outcome After Major Vascular Surgery
Jarai R, Mahla E, Perkmann T, et al. Am J Cardiol 2011;108:1188-95.
Conclusion: Copeptin is a new biomarker that potentially improves
prediction of perioperative and postoperative outcomes in vascular surgery
patients.
Summary: The revised cardiac risk index, the so-called Lee index, is
used widely to determine preoperative risk of surgical patients (Lee TH et al,
Circulation 1999;100:1043-49). Arginine vasopressin (AVP), an antidi-
uretic hormone, is important in the regulation of cardiovascular homeosta-
sis. It also affects platelet aggregation and release of von Willebrand factor
(Katan M et al, Crit Care 2008;12:117). Many factors play a role in
perioperative myocardial infarction, including hypertension, platelet aggre-
gation, fibrinolytic activity, and hypercoagulability. Some of these are influ-
enced by AVP. The authors postulate enhanced AVP secretion before
surgery could potentially make patients susceptible to perioperative myocar-
dial events; however, for a variety of reasons, AVP itself is unsuitable as a
biomarker for routine clinical practice. The C-terminal fragment of the
provasopressin peptide, copeptin, is secreted in equimolar amounts with
t
rVP. Copeptin can be reliably determined with a chemiluminescence assay
Morgenthaler NG et al, Clin Chem 2006;52:112-9). The purpose of this
eport was to determine whether copeptin levels the day before elective
ascular surgery identified high-risk patients. There were 189 consecutive
atients who underwent major vascular surgery. Infrainguinal reconstruc-
ions accounted for 58.6%, abdominal aortic aneurysm surgery for 23.7%,
nd carotid endarterectomy for 17.7%. In-hospital and 2-year major cardiac
dverse event rates (cardiac death, nonfatal myocardial infarction, emer-
ency coronary revascularization) were monitored. Forty patients (20.2%)
eached the primary end point. Most events occurred during the index
ospital stay, 45%. By univariate analysis, increasing concentrations of co-
eptin as a continuous variable were significant determinants of outcome
hazard ratio [HR], 1.012; P  .005) and as a dichotomized variable using
he recommended cutoff of 14.0 pmol/L (HR, 4.116; P  .001). Patients
t low estimated risk according to N-terminal pro-B-type natriuretic peptide
NT-pro-BNP) levels were at a significantly higher risk for worse outcomes
ith higher copeptin levels (HR, 5.983; P  .002). Multivariate Cox
egression analysis demonstrated copeptin concentrations 14 pmol/L
ere independent predictors of outcome (HR, 2.842; P  .002). This was
n addition to type of surgery, history of myocardial infarction, and eleva-
ions of cardiac troponin T and NT-pro-BNP levels. Higher copeptin levels
ere additive to the Lee index (14 pmol/L; HR, 4.059; 95% confidence
nterval, 2.18-7.57; P  .001) and to the Eagle score (HR, 3.26; 95%
onfidence interval, 1.72-6.17; P  .001) for estimating postoperative
utcomes.
Comment: There is the possibility, because of the small number of
atients in this study, the authors actually underestimated the association of
opeptin concentrations with cardiac events after major vascular surgery. It
ollows they may also underestimate the additional predictive value of
opeptin concentrations to more established risk factor assessment, such as
he Lee index, NT-pro-BNP, and Eagle criteria. In addition, patients
ntered this study between 2002 and 2003, and techniques of anesthesia and
ascular surgery have changed significantly since then. The authors’ results,
herefore, while interesting, need confirmation in a larger more contempo-
ary population of vascular surgical patients.
